E-DRUG Archives (by thread)

  • [e-drug] Intraventricular dose of vancomycin?, Huma Rasheed
  • [e-drug] Questions about bioequivalency, nabil gedadi
  • [e-drug] Sri Lanka - Most tsunami drug donations were useless & dangerous, e-drug
  • [e-drug] Beyond WHO Stop TB? (2), Carolyn Green
  • [e-drug] Contents of Prescrire International, April 2007, International
  • [e-drug] WHO to launch first essential medicines list for children, e-drug
  • [e-drug] Essential medicines for chronic diseases - study, e-drug
  • [e-drug] AIDAN website, Dr Gopal Dabade
  • [e-drug] ARV Drug Supply Training, Pretoria, South Africa June 2007, BeckmannM
  • [e-drug] Help on research on ART Supply Management capacity, Alemayehulemma
  • [e-drug] WHO-led anti-counterfeiting coalition (3), Bev
  • [e-drug] Pooled Procurement of Pharmaceuticals?, Maggie Huff-Rousselle
  • [e-drug] Emerging market fuel $ 665-685bn global market, E-Drug
  • [e-drug] Neuroleptics - dangerous in Alzheimer's?, E-Drug
  • [e-drug] pooled procurement of pharmaceuticals (2), Pauline Norris
  • [e-drug] RFI: training modules on GMP?, chandrasekar kalyanram
  • [e-drug] EoI: Production unit for solid dosage forms in Arusha, Tanzania, Christoph Bonsmann
  • [e-drug] First WHO Essential Medicines List for Children up for comments, WHO EML Secretariat
  • [e-drug] Osteopenia propaganda, Pablo Alonso
  • [e-drug] RFI: training modules on GMP? (4), Sabine Kopp
  • [e-drug] Pooled Procurement of Pharmaceuticals? (4), Dr. Subhash C Mandal
  • [e-drug] VEN method Prescription Pattern Analysis?, Mohd. Tariq Salman
  • [e-drug] Generic heat stable lopinavir/ritonavir launched in India, E-Drug
  • [e-drug] APUA congress on Diagnostics in Infectious disease & resistance, Karrie-Ann Toews
  • [e-drug] Abbott drops Lopi/r to $1000 for 40 middle income countries, E-Drug
  • [e-drug] Chlorthalidone vs hydrochlorothiazide (2), Dr.ssa Maria Font
  • [e-drug] Updated link to the Abbott press release (2), Dongmo Nguimfack, Boniface
  • [e-drug] VEN method Prescription Pattern Analysis? (4), Atieno Ojoo
  • [e-drug] NGOs respond to Abbott $1000 Price for Aluvia (lop/r), B . Baker
  • [e-drug] FTAs & the Pharmaceutical Benefits Scheme in Australia, Clancy Kelly
  • [e-drug] Needed: Short-term ICT Assessment in Kenya, Maggie Huff-Rousselle
  • [e-drug] Toxicity concerns for fetus ........, Joan Ramos
  • [e-drug] Discount Price Offered for Kaletra/Aluvia - What Abbott must do next, Kannikar KIJTIWATCHAKUL
  • [e-drug] VEN method Prescription Pattern Analysis? (5), Dr. Subhash C Mandal
  • [e-drug] Thiazides and high blood pressure, Leo Offerhaus
  • [e-drug] Prices of lab equipment, consumables and supplies?, Susan Foster (APUA)
  • [e-drug] Novartis case statement by India, Alexandra HEUMBER
  • [e-drug] HPV vaccine (2), Vivien Tsu
  • [e-drug] Abbott's Blackmail Against Thailand Continues, Brook Baker
  • [e-drug] FDA Testimony opposing COX-2 inhibitor Arcoxia, Sidney Wolfe
  • [e-drug] Prices of lab equipment, consumables and supplies? (4), Robert Buizert
  • [e-drug] Emergency Buffer Stock Supply for the Supply of key HIV & AIDS Products, e-drug
  • [e-drug] Minimum qualification required for registration as pharmacist., Dr. Subhash C Mandal
  • [e-drug] MSF is recruiting a pharmacist, Cecile MACE
  • [e-drug] WHO publishes 15th edition Model EML, Wilbert Bannenberg
  • [e-drug] Drug information centres in india, kspcdic
  • [e-drug] Generic medicines studies, nabil gedadi
  • [e-drug] New database for neglected diseases' medicines development, E-Drug
  • [e-drug] African Association of Essential Drugs: "DAKAR DECLARATION", Gerard Millot
  • [e-drug] MSF looks for a Senior Pharmacist full time in Geneva, Fernando . PASCUAL
  • [e-drug] MSF looks for a Senior Pharmacist full time in Geneva (full TOR), Fernando . PASCUAL
  • [e-drug] Controversy around HPV vaccine, Lambert Marie
  • [e-drug] Course Announcement - Pharmacotherapy teaching - Spanish, pmordujo
  • [e-drug] Novartis response to case statement by India, Dominic Atkins
  • [e-drug] Thailand, Abbott & the Second Line HIV Crisis: Teleconf & MSF briefing, Buddhima Lokuge
  • [e-drug] Analysing pharmaceutical policy in Europe, Lambert Marie
  • [e-drug] New website about/for Pakistan Pharmacists, Pakistan Pharmacists
  • [e-drug] Policy to purchase generics only in Latin America?, Alix Beith
  • [e-drug] International Health Workforce Conference: proceedings now available, Tana Wuliji
  • [e-drug] Abbott wrong to target Thailand, Kannikar KIJTIWATCHAKUL
  • [e-drug] Analysing pharmaceutical policy in Europe (4), Thomsen, Trine Lyager (CPS-HTP)
  • [e-drug] Open Letter of LAC Civil Society to Thailand, gabriela
  • [e-drug] International Health Workforce Conference: proceedings now available (2), Tana Wuliji
  • [e-drug] Brazil declares Efavirenz to be of public interest, gabriela
  • [e-drug] Open letter from HAI Africa and EPN to Abbott's Shareholders, HAI Africa
  • [e-drug] Update on formulary for a tertiary care hospital, Atieno Ojoo
  • [e-drug] Brazilian Government declares Efavirenz to be of public interest, gabriela
  • [e-drug] WHO: A turning point for a billion people or for billionaires?, "Jörg Schaaber"
  • [e-drug] Merck on the Brazilian move towards CL efavirenz, gabriela
    • Mail converted by MHonArc 2.6.8